AML Patients Receiving PKC412 Midostaurin Show 23% OS Improvement in Phase III Trial December 25, 2015Vol.38 No.12
Head-to-Head Phase III Study Demonstrates Kyprolis Nearly Doubles PFS over Velcade December 25, 2015Vol.38 No.12
Drugs & Targets Amgen submits expanded application for Kyprolis in the EU December 11, 2015Vol.41 No.45
Drugs & Targets FDA clears cooling cap for preventing hair loss during chemotherapy December 11, 2015Vol.41 No.45
In Brief Baylor to collaborate with Biocept on blood-based cancer tests December 11, 2015Vol.41 No.45
Drugs & Targets FDA approves Vistogard for emergency treatment of certain chemotherapy overdoses December 11, 2015Vol.41 No.45
In Brief Terrill Jordan named president and CEO of Regional Cancer Care Associates December 11, 2015Vol.41 No.45
